Fate-mapping and functional dissection reveal perilous influence of type I interferon signaling in mouse brain aging

• Published in: Molecular neurodegeneration Vol. 19; no. 1; pp. 48 - 12
• Main Authors: Roy, Ethan R, Li, Sanming, Saroukhani, Sepideh, Wang, Yanyu, Cao, Wei
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 18.06.2024; BioMed Central; BMC
• Subjects: Aging; Aging - metabolism; Animals; Biological response modifiers; Brain; Brain - metabolism; Brain - pathology; Interferon; Interferon Type I - metabolism; Mice; Microglia - metabolism; Microglia, Brain; Nervous system diseases; Neuroinflammation; Neurons; Neurons - metabolism; Neurophysiology; Receptor, Interferon alpha-beta - metabolism; RNA sequencing; Signal Transduction - physiology; Surgery; Surveys; Aging; Neuroinflammation; Interferon; Microglia, Brain
• ISSN: 1750-1326; 1750-1326
• DOI: 10.1186/s13024-024-00736-6

Aging significantly elevates the risk of developing neurodegenerative diseases. Neuroinflammation is a universal hallmark of neurodegeneration as well as normal brain aging. Which branches of age-related neuroinflammation, and how they precondition the brain toward pathological progression, remain ill-understood. The presence of elevated type I interferon (IFN-I) has been documented in the aged brain, but its role in promoting degenerative processes, such as the loss of neurons in vulnerable regions, has not been studied in depth. To comprehend the scope of IFN-I activity in the aging brain, we surveyed IFN-I-responsive reporter mice at multiple ages. We also examined 5- and 24-month-old mice harboring selective ablation of Ifnar1 in microglia to observe the effects of manipulating this pathway during the aging process using bulk RNA sequencing and histological parameters. We detected age-dependent IFN-I signal escalation in multiple brain cell types from various regions, especially in microglia. Selective ablation of Ifnar1 from microglia in aged mice significantly reduced overall brain IFN-I signature, dampened microglial reactivity, lessened neuronal loss, restored expression of key neuronal genes and pathways, and diminished the accumulation of lipofuscin, a core hallmark of cellular aging in the brain. Overall, our study demonstrates pervasive IFN-I activity during normal mouse brain aging and reveals a pathogenic, pro-degenerative role played by microglial IFN-I signaling in perpetuating neuroinflammation, neuronal dysfunction, and molecular aggregation. These findings extend the understanding of a principal axis of age-related inflammation in the brain, one likely shared with multiple neurological disorders, and provide a rationale to modulate aberrant immune activation to mitigate neurodegenerative process at all stages.